Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Immunotherapy × Sarcoma × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11 Thoracic 8 Breast 3 Sarcoma 1 Other solid neoplasm 1 Genitourinary 1

Conditions

Sarcoma 1 Radiation Injuries 1

Interventions

Doxorubicin 7 Cyclophosphamide 6 X-Rays 3 Vincristine 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Ifosfamide 3 polatuzumab vedotin 2 pemigatinib 2 liposomal doxorubicin 2 glofitamab 2 fludarabine 2 envafolimab 2 anlotinib 2 Radiotherapy 2 Prednisone 2 Injections 2 Imatinib Mesylate 2 Etoposide 2 Biopsy 2 AZD 6244 2 toripalimab 1 surufatinib 1 relmacabtagene autoleucel 1 regorafenib 1 perflutren 1 pazopanib 1 obinutuzumab 1 montelukast 1 lenvatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07396116 2026-02-12

FUSION-02

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Not yet recruiting

Radiation Injuries, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡